$ALOG (Analogic Corp)

$ALOG {{ '2016-06-01T21:39:15+0000' | timeago}} • Webcast

$ALOG said its Ultrasound total revenue in FY16 is expected to be up modestly in spite of a drag from legacy OEM probes, and direct sales are expected to be up double digits. OEM legacy probes is expected to stabilize at $12-14MM a year. The company said that North America and Asia direct sales continue growing at double digits.

$ALOG {{ '2017-07-13T21:40:13+0000' | timeago}} • Announcement

$ALOG announced that Michael Bourque has been appointed its CFO and Treasurer, effective July 13, 2017. He replaces Mark Frost, who will be leaving the company. Bourque joined Analogic in 2014 as VP and Corporate Controller.

$ALOG {{ '2017-06-06T20:44:38+0000' | timeago}} • Announcement

$ALOG BoD declared a $0.10 cash dividend for each common share for 3Q17. The cash dividend will be payable on June 30, 2017, to shareholders of record on June 16, 2017.

$ALOG {{ '2017-06-06T20:44:07+0000' | timeago}} • Announcement

For FY17, $ALOG expects total revenue to be down low to mid-single digits compared with FY16 with non-GAAP operating margins in the range of 8.5-9.5%. The above guidance is expected to result in a non-GAAP EPS of between $2.40-2.70.

$ALOG {{ '2017-06-06T20:37:51+0000' | timeago}} • Announcement

Healthcare and security technology solutions provider $ALOG posted a net loss for 3Q17, hurt by restructuring and asset impairment charges. Net loss for the quarter was $59.65MM or $4.78 loss per share vs. a net income of $4.97MM or $0.40 per share a year ago. Revenue declined 4.54% to $122.16MM. Excluding items, $ALOG earned $0.79 per share.

$ALOG {{ '2017-03-07T12:02:58+0000' | timeago}} • Announcement

$ALOG's BoD on Feb. 28, 2017 declared a $0.10 cash dividend for each common share for its 2Q17. The dividend will be payable on March 31, 2017, to shareholders of record on March 17, 2017.

$ALOG {{ '2017-03-07T12:00:51+0000' | timeago}} • Announcement

$ALOG expects FY17 revenue to be flat compared with FY16 non-GAAP operating margins of 10-11.5% resulting in non-GAAP EPS of $3.00-3.45. For FY18, $ALOG expects revenue to be down low-single digits and non-GAAP operating margins to be up about 1 point.

$ALOG {{ '2017-03-07T11:59:01+0000' | timeago}} • Announcement

$ALOG said it will incur restructuring related charges of up to $5MM in FY17 of which $0.5MM was recorded in 2Q17. $ALOG expects that these changes to result in mid-single digit non-GAAP operating margins with revenue flat-to-down low-single digits in its Ultrasound business for FY18 with growth into FY19.

$ALOG {{ '2017-03-07T11:56:34+0000' | timeago}} • Announcement

$ALOG plans to resize its U.S. sales and global marketing as well as general and administration organizations in-line with its objectives. These will result in a workforce reduction of about 130 employees generating an expected run rate savings of $12-15MM in FY18, principally in its ultrasound business. These will be completed by end of FY17.

$ALOG {{ '2017-03-07T11:56:11+0000' | timeago}} • Announcement

$ALOG said it will consolidate the activities currently conducted in Vancouver, British Columbia with its existing operations in Copenhagen, Denmark and Peabody, Massachusetts and plans to exit the Vancouver facility by end of FY17.

$ALOG {{ '2017-03-07T11:54:20+0000' | timeago}} • Announcement

$ALOG announced a restructuring of its Ultrasound business designed to improve profitability and provide consistent long-term growth. The company plans to focus on its core markets of urology and surgery as well as specific areas of the point of care market where its products have a competitive advantage.

$ALOG {{ '2017-03-07T11:53:08+0000' | timeago}} • Announcement

$ALOG swung to a 2Q17 profit from a loss last year, on benefit from a contingent adjustment associated with lower revenues from the Oncura acquisition. Net income was $7.51MM or $0.59 per share compared to a loss of $2.99MM or $0.24 per share last year. Revenue grew to $131.53MM from $127.87MM. Non-GAAP EPS fell to $0.99 from $1.18.

$ALOG {{ '2016-12-07T18:33:40+0000' | timeago}} • Webcast

$ALOG's Ultrasound Direct segment grew by 7% in 1Q17, driven by Asia and North America point of care and vet. The company is expecting flat to low revenue growth for the year in this segment. Security grew 36% for the quarter, with higher revenue across all pipelines.

$ALOG {{ '2016-12-07T18:25:41+0000' | timeago}} • Webcast

$ALOG said it expects some improvement going forward in gross margin from current levels. On a segment basis, the company grew Medical Imaging by 3% in 1Q17, driven by strong double-digit performance in MRI and expects Medical Imaging to end the year relatively flat.

$ALOG {{ '2016-12-06T22:14:38+0000' | timeago}} • Announcement

$ALOG BoD declared a $0.10 cash dividend for each common share for 1Q17, payable on Dec. 30, 2016, to shareholders of record on Dec. 16, 2016.

$ALOG {{ '2016-12-06T22:12:51+0000' | timeago}} • Announcement

Healthcare and security technology company $ALOG posted higher 1Q17 results, helped by higher revenue and lower cost of sales in Engineering segment. For the quarter, net income rose 83.33% to $2.53MM or $0.20 per share from $1.38MM or $0.11 per share a year ago. Revenue rose 5.36% $121.12MM. Excluding items, $ALOG earned $0.43 per share.

$ALOG {{ '2016-10-24T14:24:27+0000' | timeago}} • Announcement

$ALOG said its President and CEO James Green will retire from his position as a member of BoD, effective Oct. 31, 2016. The Board has appointed Dr. Fred B. Parks, Executive Chairman and CEO of Enovate Medical, as the company's new President and CEO.

$ALOG {{ '2016-10-11T14:07:09+0000' | timeago}} • Announcement

$ALOG appointed Mark Laustra as VP, Global Business Development and Government Relations for its security business. Mark will lead the rollout of company's most advanced solution for aviation checkpoint, ConneCT Checkpoint Computed Tomography Screening System.

$ALOG {{ '2016-09-22T08:27:10+0000' | timeago}} • Webcast

In 4Q16, $ALOG's GAAP OpEx increased due to restructuring and BK Medical distributor settlement related expenses. Due to unfavorable geographic mix, tax rate grew 7% to 35% in the quarter. Company expects FY17 tax rate to be at the high 20% level. $ALOG ended FY16 with $33MM of operating cash flow and $20MM of free cash flow.

$ALOG {{ '2016-09-22T08:26:34+0000' | timeago}} • Webcast

For the long-term, $ALOG expects upper single digit net revenue growth, with double-digit growth and accelerating margin for the direct ultrasound segment. Medical imaging is expected to grow low single digit. Company expects non-GAAP operating margin to rise in the mid-teens and expects double-digit growth in non-GAAP EPS.

$ALOG {{ '2016-09-22T08:26:13+0000' | timeago}} • Webcast

For FY17, $ALOG expects ultrasound segment revenue to grow in the mid-teens, with operating margin improving to mid-single digits. Medical imaging revenue is expected to be flat, with high teens operating margin. Security and detection revenue is expected to grow double-digit, with mid-teens operating margin.

Recent Transcripts

PLXS (Plexus Corp.)
Thursday, July 20 2017 - 12:30pm
PKE (Park Electrochemical Corp.)
Wednesday, June 28 2017 - 3:00pm
MEI (Methode Electronics, Inc.)
Thursday, June 22 2017 - 3:00pm
JBL (Jabil Circuit Inc.)
Wednesday, June 14 2017 - 8:30pm
ALOG (Analogic Corp)
Tuesday, June 6 2017 - 9:00pm
UQM (UQM Technologies Inc.)
Thursday, May 11 2017 - 8:30pm
SPA (Sparton Corp.)
Wednesday, May 10 2017 - 3:00pm
Wednesday, May 10 2017 - 1:00pm
VPG (Vishay Precision Group, Inc.)
Tuesday, May 9 2017 - 2:00pm
CVU (CPI Aerostructures Inc.)
Tuesday, May 9 2017 - 12:30pm
UEIC (Universal Electronics Inc.)
Thursday, May 4 2017 - 8:30pm
ATRO (Astronics Corp)
Thursday, May 4 2017 - 3:00pm
TSLA (Tesla, Inc.)
Wednesday, May 3 2017 - 9:30pm
VSH (Vishay Intertechnology Inc.)
Wednesday, May 3 2017 - 1:00pm
PKE (Park Electrochemical Corp.)
Tuesday, May 2 2017 - 3:00pm
LBY (Libbey Inc.)
Tuesday, May 2 2017 - 3:00pm
STS (Supreme Industries Inc.)
Monday, May 1 2017 - 1:00pm
B (Barnes Group Inc.)
Friday, April 28 2017 - 12:30pm
CTS (CTS Corporation)
Thursday, April 27 2017 - 3:00pm
TER (Teradyne Inc.)
Thursday, April 27 2017 - 2:00pm

AlphaGraphics you may like